British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Microbial-based and microbial-targeted therapies for inflammatory bowel diseases

A Oka, RB Sartor - Digestive diseases and sciences, 2020 - Springer
Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
pouchitis, are chronic, relapsing intestinal inflammatory disorders mediated by dysregulated …

ACG clinical guideline: management of Crohn's disease in adults

GR Lichtenstein, EV Loftus, KL Isaacs… - Official journal of the …, 2018 - journals.lww.com
Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic,
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …

3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations

P Gionchetti, A Dignass, S Danese… - Journal of Crohn's …, 2017 - academic.oup.com
This paper is the second in a series of two publications relating to the European Crohn's and
Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management …

Management of Crohn's disease in adults

GR Lichtenstein, SB Hanauer… - Official journal of the …, 2009 - journals.lww.com
Guidelines for clinical practice are intended to suggest preferable approaches to particular
medical problems as established by interpretation and collation of scientifically valid …

AGA technical review on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease

S Singh, D Proctor, FI Scott, Y Falck-Ytter… - Gastroenterology, 2021 - Elsevier
The incidence and prevalence of Crohn's disease (CD) is rising globally. Patients with
moderate to severe CD are at high risk for needing surgery and hospitalization and for …

Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events

A Kunchok, AJ Aksamit, JM Davis, OH Kantarci… - JAMA …, 2020 - jamanetwork.com
Importance Tumor necrosis factor (TNF) inhibitors are common therapies for certain
autoimmune diseases, such as rheumatoid arthritis. An association between TNF inhibitor …

[HTML][HTML] Use of thiopurines in inflammatory bowel disease: an update

A Singh, R Mahajan, S Kedia, AK Dutta… - Intestinal …, 2022 - synapse.koreamed.org
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere,
has emerged as a global disease. As the disease prevalence is on a steady rise …

Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease

BL Cohen, DB Sachar - Bmj, 2017 - bmj.com
The treatment of inflammatory bowel disease (IBD)—ulcerative colitis (UC) and Crohn's
disease (CD)—has evolved beyond surgery with the introduction of biologic agents …

Kono-S anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn's disease: an international multicenter study

T Kono, A Fichera, K Maeda, Y Sakai, H Ohge… - Journal of …, 2016 - Elsevier
Abstract Introduction The Kono-S (antimesenteric functional end-to-end handsewn)
anastomosis has been used for Crohn's disease in Japan and the USA since 2003 and …